Newer Biomarkers in Gallbladder Carcinoma: A Scoping Review
2024

New Biomarkers in Gallbladder Cancer

publication Evidence: moderate

Author Information

Author(s): Muacevic Alexander, Adler John R, Upadhyay Amitabh Kumar, Nag Deb Sanjay, Jena Sanghamitra, Sinha Neetesh, Lodh Dona

Primary Institution: Tata Main Hospital, Jamshedpur, IND

Hypothesis

Biomarkers can improve management and outcomes for gallbladder cancer patients post-surgery.

Conclusion

The study highlights the potential of various biomarkers to enhance patient care and improve long-term survival rates in gallbladder cancer.

Supporting Evidence

  • Biomarkers can help identify patients at risk of cancer recurrence after surgery.
  • Some biomarkers are already in clinical use, while others are still being researched.
  • Integrating biomarker data into treatment plans can personalize therapy.

Takeaway

Scientists are looking for special markers in gallbladder cancer that can help doctors know which treatments will work best for patients.

Methodology

The authors conducted a scoping review by searching PubMed, Scopus, and Web of Science databases for relevant articles from January 2000 to December 2023.

Limitations

The clinical application of many newer biomarkers remains limited and requires further research.

Digital Object Identifier (DOI)

10.7759/cureus.75142

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication